Discovery proteomics · targeted LC–MS · data integration

Separate the signals. Integrate the evidence.

An anonymous demonstration of how complementary proteomics datasets can be quality-controlled, separated within a mixed-species biological system, and combined to distinguish shared responses from system-specific biology.

Explore the datasets Review the workflow

3 data viewscomplementary proteomics evidence

Species-awarepeptide-level identity separation

QC firstmissingness and outlier review

Pathway-linkedmechanistic interpretation

Anonymousmodified demonstration values

Analytical workflow

One sample can contain several layers of evidence.

The challenge is not merely to combine tables. Each measurement strategy has a different purpose, and mixed-species peptides must be resolved before treatment effects or pathways can be interpreted.

01 / REVIEW

Inspect each dataset

Evaluate identification quality, contaminants, missingness, sample composition, and technical behavior separately.

02 / RESOLVE

Assign peptide identity

Retain species-specific and protein-specific evidence while flagging sequences that cannot support attribution.

03 / NORMALIZE

Prepare comparable values

Summarize technical replicates, apply dataset-appropriate normalization, and transform abundance values.

04 / INTEGRATE

Connect complementary results

Combine supported findings without pretending that broad, enriched, and targeted measurements are interchangeable.

05 / INTERPRET

Test biological coherence

Map orthologs, review pathways, and compare inferred mechanisms with independent experimental evidence.

Interactive dataset explorer

What does each proteomics layer contribute?

Select a data view to see its analytical role, the main quality consideration, and how it contributes to the integrated conclusion.

Broad discovery

Proteome-wide hypothesis generation

Discovery layer

Analytical purposeMaximize molecular coverageProfiles broad protein changes without restricting the analysis to a predefined panel.

Main quality checkSample compositionSpecies balance, missingness, contaminants, and outlying profiles are reviewed before comparison.

Integrated contributionPathway discoveryProvides the broad protein set used to identify coordinated biological responses.

CoverageHigh

SpecificityModerate

Quantitative focusBroad

Interpretation: Broad discovery creates biological context, but targeted evidence is still valuable when predefined proteins require more focused measurement.

Cross-system pathway view

Switch between anonymous biological systems to see how integrated protein evidence can support shared and divergent responses.

System A: The integrated evidence supports adaptive metabolic signaling without a strong proliferation-associated response.

Evidence interpretation lens

The conclusion is strongest when results from different measurement strategies agree and an independent biological endpoint points in the same direction.

✓

Concordant targeted evidence

Focused measurements retained the direction of selected discovery signals.

✓

Species-aware interpretation

Only assignable peptide and ortholog evidence was used for cross-system comparisons.

✓

Independent experimental support

A separate biological endpoint agreed with the main system-specific interpretation.

Exploratory statistical scope

Small experimental groups and nominal testing limit broad generalization; this is not a biomarker-validation claim.

What this demonstrates

Integration should preserve what each method can prove.

Discovery, enrichment, and targeted proteomics become more informative when their different coverage and specificity are respected rather than collapsed into one undifferentiated table.

Separate before comparing

Resolve species and protein identity before interpreting abundance differences.

Combine complementary evidence

Use broad analysis for context and focused assays for selected quantitative questions.

Distinguish shared and divergent biology

Ortholog mapping helps identify responses that agree—or separate—across biological systems.

Keep claims proportional

Mechanistic evidence can guide interpretation without being presented as clinical or biomarker validation.

Demonstration scope

Analytical logic retained. Study identity removed.

This public-facing case is derived from a peer-reviewed integrated proteomics workflow. It illustrates the analysis strategy without reproducing the publication or attributing the work to QuantiraOmics.

What remains scientifically representative

Combination of broad discovery, enrichment-based, and targeted proteomics.
Quality control and separate processing of heterogeneous proteomics outputs.
Species-specific peptide classification and cross-system ortholog mapping.
Pathway interpretation supported by an independent biological endpoint.

What has been anonymized or modified

Treatment, organ, authors, affiliations, study groups, sample counts, protein identities, instruments, software versions, thresholds, pathways, dates, and empirical values are omitted or changed.

What the example does not claim

The displayed values do not reproduce the publication.
The study is not presented as a biomarker-development or clinical-validation project.
No client, employer, proprietary, patient, or unpublished information is disclosed.

This anonymous educational demonstration preserves the general analytical problem and workflow while removing identifying and exact empirical details.